홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /화합물

(S)-(+)-이부프로펜

Dexibuprofen

HCID 39912
새 반응
인쇄
기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트
부분 구조 검색유사 구조 찾기

기본 정보

CAS
51146-56-6
표준 SMILES
CC(C)Cc1ccc([C@H](C)C(=O)O)cc1
InChIKey
HEFNNWSXXWATRW-JTQLQIEISA-N
분자식
C13H18O2
평균 분자량
206.28 g/mol
단동위원소 질량
206.13067981

개요

Dexibuprofen is an ibuprofen. It has a role as a non-steroidal anti-inflammatory drug and a non-narcotic analgesic. It is an enantiomer of a levibuprofen.

이름 및 식별자

우선 이름
Dexibuprofen
IUPAC
(2S)-2-[4-(2-methylpropyl)phenyl]propanoic acid
현지명
(S)-(+)-이부프로펜
영어명
(S)-(+)-Ibuprofen
분자식
C13H18O2
분자량
206.28

이름 및 동의어

DEXIBUPROFEN51146-56-6DexibuprofeneDexibuprofenoSeractild-IbuprotenDexibuprofenum(+)-(S)-p-Isobutylhydratropic acid(+)-Ibuprofen(2S)-2-(4-isobutylphenyl)propanoic acids-ibuprofen(2S)-2-[4-(2-methylpropyl)phenyl]propanoic acid
이름 더 보기
(S)-(+)-이부프로펜(S)-IBUPROFEN(S)-2-(4-Isobutylphenyl)propanoic acidRamelteon-7d-IbuprofenexibuprofenDeibuprofenDextroprofen
DTXSID9048724NSC-759814671DKG7P5S(S)-alpha-methyl-4-(2-methylpropyl)benzeneacetic acidDTXCID6028650CHEBI:43415Benzeneacetic acid, alpha-methyl-4-(2-methylpropyl)-, (S)-(2S)-2-(4-(2-methylpropyl)phenyl)propanoic acid

데이터베이스 식별자

CAS
51146-56-6
PubChem CID
39912
DTXSID
DTXSID9048724
ChEMBL
CHEMBL175
ChEBI
CHEBI:43415
UNII
671DKG7P5S
EC Number

물성

구조 계산 물성

XLogP
3.5
극성 표면적
37.3 Ų
수소 결합 공여자 수
1
수소 결합 수용자 수
2
회전 가능 결합 수
4
무거운 원자 수
15
형식 전하
0
복잡도
203

실험 및 물리화학적 성질

Drugs · 2건

Pharmaceuticals -> Listed in ZINC15

Pharmaceuticals -> Used in Switzerland

SolubilityInsoluble
Melting Point49-53

물리화학적 성질

녹는점
49 · 49-53 °C(lit.)
끓는 점
285.14 °C · 285.14°C (rough estimate)
밀도
1.0364 · 1.0364 (rough estimate)
굴절률
59 ° · 59 ° (C=2, EtOH)
인화점
230 °F · >230 °F
저장 조건
Sealed in dry,Room Temperature
용해도
45 % · 45%(w/v) 수성 2-히드록시프로필-β-시클로덱스트린: 1.5mg/mL
물리적 상태
고체
산도 계수 (pKa)
4.41 · 4.41±0.10(Predicted)
색상
하얀색
수용성
불용성
BRN
3590022 · 3590022
안정성
안정적인. 강한 산화제와 호환되지 않습니다.

안전 및 규제

안전 정보는 참고용이며, 공급업체의 물질안전보건자료(SDS), 관련 법규 및 전문가 평가를 대체하지 않습니다.

GHS 분류

GHS Classification · 4건

Warning

H302 (85.7%): Harmful if swallowed [Warning Acute toxicity, oral]

P203, P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P318, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 7 reports by companies from 4 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

유해성 정보

Hazard Classes and CategoriesAcute Tox. 4 (85.7%)

안전 데이터

wgk
3
HS 번호
2916399090
risk_code
63-22
hazard_code
Xn
safety_code
45-36/37
스토리지 클래스
11 - Combustible Solids

화학 및 산업

약리 정보

ATC Code · 2건

M - Musculo-skeletal system

QM - Musculo-skeletal system

Protein BindingFor more information, refer to [ibuprofen].
PharmacodynamicsFor more information, refer to [ibuprofen].
Mechanism of Action · 1건

Like common NSAIDs, dexibuprofen is an active enantiomer of [ibuprofen] that suppresses the prostanoid synthesis in the inflammatory cells via inhibition of the COX-2 isoform of the arachidonic acid COX. For more information, refer to [ibuprofen].

Biological Half-LifeOral tablets containing 300mg of dexibuprofen results in 2.2-4.7 hours. For more information, refer to [ibuprofen].
Metabolism/Metabolites · 2건

For more information, refer to [ibuprofen].

(S)-(+)-ibuprofen has known human metabolites that include 2-Hydroxyibuprofen and 3-Hydroxyibuprofen.

Absorption, Distribution and Excretion · 4건

The time it take to reach peak plasma concentration is 2.25-5 hours post-administration of oral tablets containing 300mg of dexibuprofen. For more information, refer to [ibuprofen].

Mainly renal excretion. For more information, refer to [ibuprofen].

For more information, refer to [ibuprofen].

For more information, refer to [ibuprofen].

용도 및 제조

UsesUse (kg) in Switzerland (2009): >25000
응용 분야 · 3건

관련 반응

15건
반응 기록 만들기
HRID 220715 반응식
HRID 220715반응물로
HRID 356841 반응식
HRID 356841반응물로
HRID 391197 반응식
HRID 391197반응물로
HRID 511942 반응식
HRID 511942반응물로
HRID 864689 반응식
HRID 864689생성물로
HRID 1467862 반응식
HRID 1467862반응물로
HRID 1589944 반응식
HRID 1589944반응물로
HRID 1609246 반응식
HRID 1609246반응물로
이전1 / 2 페이지

화합물 노트

이 페이지에서기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트
610-620-9
Nikkaji
J384.813B
InChI
1S/C13H18O2/c1-9(2)8-11-4-6-12(7-5-11)10(3)13(14)15/h4-7,9-10H,8H2,1-3H3,(H,14,15)/t10-/m0/s1
InChIKey
HEFNNWSXXWATRW-JTQLQIEISA-N
SMILES
CC(C)Cc1ccc(cc1)[C@H](C)C(O)=O

화학적 성질

Colourless, Crystalline Solid

개요Dexibuprofen, the S-(+)-isomer of the widely used NSAID agent ibuprofen, was launched in Austria for the treatment of rheumatoid arthritis. While the racemic compound is commonly used clinically, the antiinflammatory activity is mediated via the S-isomer by inhibition of prostaglandin synthesis. It has also been demonstrated that the R-isomer is converted to the Santipode in vivo via a CoA thioester intermediate. Since CoA plays a pivotal role in intermediary metabolism and maintenance of the [acyl-CoA], generation of R-ibuprofen-CoA competitively inhibits many CoA-dependent reactions, which consequently produces perturbations of hepatocyte Intermediary metabolism and mitocondrial function. Pure S-ibuprofen usage, therefore, is preferred allowing a reduction in dosage level and an improved side effect profile.

용도A nonsteroidal anti-inflammatory drug (NSAID); activity resides primarily in the (S)-isomer

일반 설명(S)-(+)-Ibuprofen is the enantiomer associated with the anti-inflammatory action of ibuprofen, which is widely used as a nonsteroidal anti-inflammatory drug in racemic form.

상·하류 제품 정보

상류 원료

1-Deoxy-1-(octylamino)-D-glucitol(R)-(=)-4-이소프로필-2-옥스아조리디논